Plasma Free Amino Acid Profiling as a Novel Screening Marker for Non Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Higashiyama, Masahiko [1 ]
Maeda, Jun [1 ]
Nakayama, Tomio [2 ]
Imamura, Fumio [2 ]
Imaizumi, Akira
Yamamoto, Hiroshi
Ando, Toshihiko
机构：
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Surg, Osaka, Japan
[2] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Resp Med, Osaka, Japan
来源：
TUMOR BIOLOGY | 2008年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [41] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [43] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [44] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [45] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Imaging mutations in non small cell lung cancer (NSCLC)
    Haslop, Anna
    Robins, Edward George
    Goggi, Julian Luke
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S337 - S337
  • [47] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
  • [48] Characteristics of clonal hematopoiesis (CH) in patients with non-small cell lung cancer (NSCLC): A retrospective analysis of plasma cell-free DNA (cfDNA) comprehensive genomic profiling
    Tagliamento, M.
    Vasseur, D.
    Bayle, A.
    Aldea, M.
    Gazzah, A.
    Nicotra, C.
    Hollebecque, A.
    Planchard, D.
    Frelaut, M.
    Botticella, A.
    Levy, A.
    Lacroix, L.
    Marzac, C.
    Micol, J. B.
    Ponce, S.
    Rouleau, E.
    Italiano, A.
    Besse, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S110 - S110
  • [49] Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).
    Karim, N.
    Pathrose, J.
    Fathallah, H.
    El Desouki, I.
    Perry, A.
    Starnes, S.
    Morris, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S714 - S715
  • [50] Tumor hyaluronan (HA) as a novel biomarker in non-small cell lung cancer (NSCLC).
    Gong, Jun
    Guan, Michelle
    Galen, Cook-Wiens
    Larson, Brent K.
    Zhou, Jenny
    Patel, Rishi
    Lapite, Isaac
    Tuli, Richard
    Natale, Ronald B.
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345